We all embark on the journey for different reasons, at different times in our lives.   Deciding to join Positive Choice was easy for me. It met my scientific expectations and it “got at” some of the underlying issues that cause us to eat and gain weight.  It also addresses the social factors and incorporates a group dynamic important for the psychological aspects.

Many have been successful and yes, some have not succeeded – YET.   Is it failure?  Only they can say.  I attended my first group meeting and got the low down on the godown…  and nibbled away at my “last suppers” on my way to week two.  THAT is the beginning of …THE PRODUCT!    Our group facilitator recommended going home and giving the product (Optifast 70) a try rather than waiting until the next morning.

Also, in week two, Positive Choice staff (It is medically supervised) gave me a letter indicating what medications and supplements I was to stop.  Being diabetic, that meant stopping all insulin and diabetic prescriptions.  I am also a cardiac patient and was directed to stop taking my daily diuretic.   So, there was not much issue with any of the changes I needed to make.  With one exception – I am involved in a diabetic study and take a placebo or possibly the drug.  But, I don’t know if I am on it or not.   In advance conversations with the medical staff at Kaiser and the study personnel, there were all sides represented.

If I were ignorant and not medically minded, I might “blindly” follow.   Which road is the correct one?  I wondered…  Positive Choice says stop taking the “pill” either the placebo or the diabetic drug.   So, I re-read the letter.  I had talked to all of the Positive Choice Staff about this issue during each interview.  I concluded that since it is a Kaiser study and my medical record is available to them AND since I had asked the question about needing to stop – the study would be short changed if we could not find a common ground.   No one would contribute information as to the consequences of NOT following the PC recommendation.  All could agree that my following the recommendation of PC would cause me to “not be a study participant”.  My letter did not address the study or the placebo.  I chose to follow the letter’s instructions.

A mild dilemma.   It is a bind study, and I choose to remain blind as well.  There will be many opportunities to discuss this situation with my care providers as well as those in PC.    In the end, protocols can be adjusted to accommodate patient’s like me.